Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 2/20 | 0.52 |
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
| ▸ | MMP1 | P03956 | 1/20 | 0.52 |
| ▸ | MMP9 | P14780 | 1/20 | 0.52 |
| ▸ | MMP8 | P22894 | 1/20 | 0.52 |
| ▸ | MMP13 | P45452 | 1/20 | 0.52 |
| ▸ | F2 | P00734 | 3/20 | 0.48 |
| ▸ | TMPRSS4 | Q9NRS4 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.46 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.46 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.46 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11574176 | 0.87 | TSHR (0.56) | MMP2CA1CA2MMP1MMP9 | |
| SCHEMBL27684445 | 0.81 | CA1 (0.48) | MMP2CA1CA2MMP1MMP9 | |
| SCHEMBL79787 | 0.79 | HSD11B1 (0.55) | MMP2CA1CA2MMP1MMP9 | |
| SCHEMBL2121770 | 0.79 | HSD11B1 (0.55) | MMP2CA1CA2MMP1MMP9 | |
| SCHEMBL30072318 | 0.79 | HSD11B1 (0.55) | MMP2CA1CA2MMP1MMP9 | |
| SCHEMBL548298 | 0.79 | MMP2 (0.54) | MMP2CA1CA2MMP1MMP9 | |
| SCHEMBL4328574 | 0.79 | HSD11B1 (0.55) | MMP2CA1CA2MMP1MMP9 | |
| SCHEMBL11573848 | 0.79 | CA12 (0.52) | MMP2CA1CA2F2TMPRSS4 | |
| SCHEMBL8696138 | 0.77 | TSHR (0.48) | MMP2CA1CA2MMP1MMP9 | |
| SCHEMBL1346329 | 0.77 | MMP2 (0.52) | MMP2CA1CA2MMP1MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111370766-A | Electrolyte containing-S-F group compound and electrochemical device thereof | 青岛滨海学院 | 2020-07-03 | — | — | CN | claimed |
| CN-107935802-A | A kind of method that biaryl compound is prepared using arylsulfonyl fluorine as raw material | 遵义医学院 | 2018-04-20 | — | — | CN | claimed |
| US-12381257-B2 | Nonaqueous electrolytic solution | CENTRAL GLASS CO, LTD. (JP) | 2025-08-05 | — | — | US | disclosed |
| WO-2025121400-A1 | PRODUCTION METHOD FOR FLUORINATED THIO GROUP–CONTAINING ARYL COMPOUND | ＡＧＣ株式会社 | 2025-06-12 | — | — | WO | disclosed |
| CN-120005064-A | Aryl ion polymer and preparation method and application thereof | 佛山绿动氢能科技有限公司 | 2025-05-16 | — | — | CN | disclosed |
| US-20250105353-A1 | Electrolyte Solution for Nonaqueous Electrolyte Batteries, and Nonaqueous Electrolyte Battery Using Same | CENTRAL GLASS COOMPANY, LIMITED (JP) | 2025-03-27 | — | — | US | disclosed |
| US-20250074942-A1 | COMPOSITIONS AND METHODS FOR COVALENT PEPTIDE-BASED MODULATORS OF HLA-E | CALICO LIFE SCIENCES LLC (US) | 2025-03-06 | — | — | US | disclosed |
| US-12199241-B2 | Electrolyte solution for nonaqueous electrolyte batteries, and nonaqueous electrolyte battery using same | CENTRAL GLASS COMPANY, LIMITED (JP) | 2025-01-14 | — | — | US | disclosed |
| CN-119264303-A | Pendant group functionalized fluorine-containing polymer, preparation method of fluorine-containing polymer, ion exchange membrane and application | 佛山绿动氢能科技有限公司 | 2025-01-07 | — | — | CN | disclosed |
| CN-119219809-A | Fluorine-containing polymer, preparation method thereof and ion exchange membrane | 佛山绿动氢能科技有限公司 | 2024-12-31 | — | — | CN | disclosed |
| CN-117954689-A | Electrolyte for nonaqueous electrolyte battery and nonaqueous electrolyte battery using same | 中央硝子株式会社 | 2024-04-30 | — | — | CN | disclosed |
| WO-2006038006-A2 | 5-SULFONYL-1-PIPERIDINYL SUBSTITUTED INDOLE DERIVATIVES AS 5-HT6 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CNS DISORDERS | GLAXO GROUP LIMITED (GB) | 2006-04-13 | — | — | WO | disclosed |
| US-7022708-B2 | 4-piperazinyl benzenesulfonyl indoles and uses thereof | ROCHE PALO ALTO LLC (US) | 2006-04-04 | — | — | US | disclosed |
| US-20050261279-A1 | Compounds | GLAXO GROUP LIMITED (GB) | 2005-11-24 | — | — | US | disclosed |
| EP-1556037-A1 | 4-PIPERAZINYL BENZENESULFONYL INDOLES WITH 5-HT6 RECEPTOR AFFINITY | F. HOFFMANN-LA ROCHE AG (CH) | 2005-07-27 | — | — | EP | disclosed |
| EP-1511727-A2 | AROMATIC SULFONES AND THEIR MEDICAL USE | GLAXO GROUP LIMITED (GB) | 2005-03-09 | — | — | EP | disclosed |
| US-20040087593-A1 | 4-Piperazinyl benzenesulfonyl indoles and uses thereof | ROCHE PALO ALTO LLC | 2004-05-06 | — | — | US | disclosed |
| WO-2004035047-A1 | 4-PIPERAZINYL BENZENESULFONYL INDOLES WITH 5-HT6 RECEPTOR AFFINITY | F. HOFFMANN-LA ROCHE AG (CH) | 2004-04-29 | — | — | WO | disclosed |
| WO-2003099786-A2 | AROMATIC SULFONES AND THEIR MEDICAL USE | GLAXO GROUP LIMITED (GB) | 2003-12-04 | — | — | WO | disclosed |
| US-4369145-A | Preparation of fluorobenzenesulfonyl fluorides by exchange fluorination | RHONE-POULENC INDUSTRIES (FR) | 1983-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050261279-A1 | Compounds | CBR1, CBR3, OXER1 | MMP2 4112/4885CA1 187/4885CA2 513/4885 |
| US-20250074942-A1 | COMPOSITIONS AND METHODS FOR COVALENT PEPTIDE-BASED MODULATORS OF HLA-E | MICA, CD74, HLA-DRB1 | MMP2 3996/4885CA1 2450/4885CA2 3905/4885 |
| US-20040087593-A1 | 4-Piperazinyl benzenesulfonyl indoles and uses thereof | HTR6, HTR4, HTR5A | MMP2 3593/4885CA1 4244/4885CA2 3132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.